Literature DB >> 19747481

Signaling effect of amyloid-beta(42) on the processing of AbetaPP.

Massimo Tabaton1, Xiongwei Zhu, George Perry, Mark A Smith, Luca Giliberto.   

Abstract

The effects of amyloid-beta are extremely complex. Current work in the field of Alzheimer disease is focusing on discerning the impact between the physiological signaling effects of soluble low molecular weight amyloid-beta species and the more global cellular damage that could derive from highly concentrated and/or aggregated amyloid. Being able to dissect the specific signaling events, to understand how soluble amyloid-beta induces its own production by up-regulating BACE1 expression, could lead to new tools to interrupt the distinctive feedback cycle with potential therapeutic consequences. Here we describe a positive loop that exists between the secretases that are responsible for the generation of the amyloid-beta component of Alzheimer disease. According to our hypothesis, in familial Alzheimer disease, the primary overproduction of amyloid-beta can induce BACE1 transcription and drive a further increase of amyloid-beta precursor protein processing and resultant amyloid-beta production. In sporadic Alzheimer disease, many factors, among them oxidative stress and inflammation, with consequent induction of presenilins and BACE1, would activate a loop and proceed with the generation of amyloid-beta and its signaling role onto BACE1 transcription. This concept of a signaling effect by and feedback on the amyloid-beta precursor protein will likely shed light on how amyloid-beta generation, oxidative stress, and secretase functions are intimately related in sporadic Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747481      PMCID: PMC2812589          DOI: 10.1016/j.expneurol.2009.09.002

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  154 in total

1.  Alzheimer's amyloid-beta peptide inhibits sodium/calcium exchange measured in rat and human brain plasma membrane vesicles.

Authors:  A Wu; C A Derrico; L Hatem; R A Colvin
Journal:  Neuroscience       Date:  1997-10       Impact factor: 3.590

2.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 3.  LRP in amyloid-beta production and metabolism.

Authors:  Guojun Bu; Judy Cam; Celina Zerbinatti
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

4.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

5.  Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins.

Authors:  Kelly T Dineley; Xuefeng Xia; Duy Bui; J David Sweatt; Hui Zheng
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

6.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.

Authors:  Mohammad Ali Faghihi; Farzaneh Modarresi; Ahmad M Khalil; Douglas E Wood; Barbara G Sahagan; Todd E Morgan; Caleb E Finch; Georges St Laurent; Paul J Kenny; Claes Wahlestedt
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

Review 7.  Wnt signaling in Alzheimer's disease: up or down, that is the question.

Authors:  Rick A C M Boonen; Paula van Tijn; Danica Zivkovic
Journal:  Ageing Res Rev       Date:  2008-12-03       Impact factor: 10.895

8.  Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.

Authors:  Giuseppina Tesco; Young Ho Koh; Eugene L Kang; Andrew N Cameron; Shinjita Das; Miguel Sena-Esteves; Mikko Hiltunen; Shao-Hua Yang; Zhenyu Zhong; Yong Shen; James W Simpkins; Rudolph E Tanzi
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

9.  Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production.

Authors:  Karen R Mowrer; Michael S Wolfe
Journal:  J Biol Chem       Date:  2008-05-08       Impact factor: 5.157

10.  Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.

Authors:  Sebum Lee; Hriday K Das
Journal:  Brain Res       Date:  2008-03-28       Impact factor: 3.252

View more
  17 in total

1.  Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models.

Authors:  Alexander M Herman; Preeti J Khandelwal; G William Rebeck; Charbel E-H Moussa
Journal:  Exp Neurol       Date:  2012-02-28       Impact factor: 5.330

2.  Amyloid and Alzheimer's disease.

Authors:  Hongxing Lei
Journal:  Protein Cell       Date:  2010-04       Impact factor: 14.870

3.  Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis.

Authors:  Jason A Bailey; Bryan Maloney; Yuan-Wen Ge; Debomoy K Lahiri
Journal:  Gene       Date:  2011-06-25       Impact factor: 3.688

Review 4.  Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease.

Authors:  Ana Gabriela Henriques; Joana Machado Oliveira; Liliana Patrícia Carvalho; Odete A B da Cruz E Silva
Journal:  Mol Neurobiol       Date:  2014-10-26       Impact factor: 5.590

5.  Amyloid-β-induced amyloid-β secretion: a possible feed-forward mechanism in Alzheimer's Disease.

Authors:  Ian T Marsden; Laurie S Minamide; James R Bamburg
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease.

Authors:  R Palacios-Pelaez; Walter J Lukiw; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2010-05-14       Impact factor: 5.590

7.  The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2011-06-15       Impact factor: 3.688

8.  Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease.

Authors:  Roger Lefort; Julio Pozueta; Michael Shelanski
Journal:  J Neurosci       Date:  2012-08-01       Impact factor: 6.167

9.  Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.

Authors:  Luana Palazzi; Benedetta Fongaro; Manuela Leri; Laura Acquasaliente; Massimo Stefani; Monica Bucciantini; Patrizia Polverino de Laureto
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

10.  Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease.

Authors:  Sathish Kumar; Jochen Walter
Journal:  Aging (Albany NY)       Date:  2011-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.